Menadex (Dexketoprofen)

Dexketoprofen blocks the activity of cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, reducing the production of prostaglandins that sensitize nerve endings. This inhibition diminishes both pain signals and the inflammatory response at the site of injury.

The appropriate dose of Menadex is determined by the prescribing healthcare professional based on the patient’s condition, age, renal and hepatic status, and other individual factors. Patients should follow the prescriber’s instructions precisely.

Safety data for dexketoprofen in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the Menadex product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Dexketoprofen is the S‑enantiomer of ketoprofen, offering faster onset of analgesia and potentially lower gastrointestinal irritation compared with some traditional NSAIDs. However, its overall safety profile remains similar, and choice of therapy should consider individual patient risk factors and clinical response.

Menadex should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in bathrooms or other humid environments.

Menadex is taken orally, usually with a full glass of water. It may be taken with or without food, but patients who experience stomach upset are advised to take it with meals to minimise gastrointestinal discomfort.

Serious risks include gastrointestinal bleeding or ulceration, severe skin reactions such as Stevens‑Johnson syndrome, renal impairment, and anaphylactic reactions. Patients should seek immediate medical attention if they notice signs of bleeding, rash, swelling, or difficulty breathing.

Menadex is contraindicated in individuals with known hypersensitivity to dexketoprofen or other NSAIDs, those with active gastrointestinal ulceration, severe renal or hepatic impairment, and patients who are currently taking anticoagulants without medical supervision.